MOMS 2The Study Continues: The trial that brought us the most significant advancement in the history of treatment of spina bifida carries on.
The next phase of MOMS continues to follow the original participants, allowing us to directly compare and better understand the long-term effects of prenatal versus postnatal repair of myelomeningocele.
Prenatal surgery to treat myelomeningocele, the most severe form of spina bifida, is one of the most exciting developments in the history of treatment for birth defects. It is also an extremely complex procedure that requires extensive experience to perform successfully. Mothers who choose fetal surgery require the most expert and carefully coordinated care from the time of diagnosis, for the spina bifida surgery itself, and through the baby's delivery and care afterwards.
Spina bifida affects about 1,500 babies born each year in the United States. A spina bifida surgery breakthrough, reported in the New England Journal of Medicine, is providing new possibilities to families faced with this devastating condition.
N. Scott Adzick, MD, director of the Center for Fetal Diagnosis and Treatment at CHOP, was lead author on the landmark Management of Myelomeningocele Study (MOMS), which proved the efficacy of prenatal spina bifida repair versus postnatal repair. The article, "A Randomized Trial of Prenatal verses Postnatal Repair of Myelomeningocele," chronicles the study conducted from 2003 to 2010 at CHOP and two other centers.
The long-awaited results validate the work pioneered by the Center team over more than 20 years; developing the prenatal repair technique, conducting extensive tests in animal models and then cautiously applying the therapy in select patients. Follow-up through 2 1/2 years of age for study participants is ongoing and will be completed in October 2013. And there is more insight to be gained.
Today, under the continued coordination of the Biostatics Center of The George Washington University and the sponsorship of Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the second phase of MOMS is underway.
The trial’s 183 families continue to be monitored to determine the long-term effects of prenatal repair of myelomeningocele with respect to adaptive behavior, physical and cognitive functioning, health and well-being, and future reproductive health of the mother. This important stage of follow-up work, continuing through November 2016, will provide valuable insight into the lasting outcomes of prenatal repair versus standard postnatal repair in children 6 to 9 years of age.
This unique opportunity to directly compare the long-term effects of prenatal versus postnatal repair will answer many questions about spina bifida, ultimately helping both clinicians and patients make an informed choice about the treatment options available.
By the Numbers 1,642Referrals for suspected Myelomeningocele (MMC)
894Evaluations for suspected MMC
199Fetal surgeries for MMC All numbers reflect data from 1995-March 2014 at The Children's Hospital of Philadelphia.
Surgeons at CHOP's Center for Fetal Diagnosis and Treatment were not only pioneers in fetal surgery, they developed the prenatal spina bifida surgery procedure and have the greatest collective experience in the world. The Center's large multidisciplinary team, including fetal surgeons, neurosurgeons, anesthesiologists, fetal cardiologists, neonatologists and radiologists, has worked together since 1995 — a level of ongoing collaboration that is unmatched.
A quick look at our patient volumes prove the Center is a valued resource for evaluation and treatment of myelomeningocele.
Specialists at the Center partner with you to provide a seamless continuum of care, discuss the diagnosis and treatment options, offer suggestions for follow-up if fetal surgery is required, and remain available for consultation for the remainder of the pregnancy as part of the patient's ongoing prenatal management team.
We welcome your questions, comments and referrals. Call us at 1-800-IN-UTERO (1-800-468-8376) or complete our online form.
To better partner with you, the Center has created a number of professional-focused resources about myelomeningocele and spina bifida, treatment options before and after birth, as well as offer you resources you can share with your patients.
This flipchart for healthcare professionals provides an overview of spina bifida, facts about myelomeningocele, when fetal surgery is a treatment option, details about the actual prenatal repair, along with recovery time, delivery and follow up care.
The document also provides volumes and metrics about treatment for myelomeningocele at The Center for Fetal Diagnosis and Treatment at CHOP.
View a dynamic PDF of the guide. Compatible with iPhone, iPad and Android devices.
This study in the New England of Journal of Medicine outlined the results of MOMS and establishes fetal surgery for spina bifida as a new standard of care.
Adzick NS, Thom EA, Spong CY, Brock III JW, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D'Alton ME, Farmer DL for the MOMS Investigators. A Randomized Trial of Prenatal Versus Postnatal Repair of Myelomeningocele. N Engl J Med 2011; 364:993-1004.
Fetal repair of myelomeningocele is now offered as a standard of care at The Children’s Hospital of Philadelphia. Download our fast facts sheet for a high-level summary of the MOMS trial, the prenatal procedure and how the Center for Fetal Diagnosis and Treatment has revolutionized treatment for children with myelomeningocele.
Comprehensive individual evaluation of each pregnancy is essential to determine whether fetal surgery for myelomeningocele is appropriate. To help you gain a clearer understanding about when prenatal surgery may be appropriate and when it is not recommended for the health of mother and/or fetus, we have developed referral guidelines for fetal surgery for myelomeningocele.
If you'd like to refer a patient to the Center for Fetal Diagnosis and Treatment for a full evaluation or discuss a case with a member of our team, please contact us at 1-800-IN-UTERO (1-800-468-8376).
The Center for Fetal Diagnosis and Treatment offers an online continuing medical education module on Fetal Myelomeningocele Repair: Tribulations and Trials. Course highlights include:
The CME is available for 1.0 AMA PRA Category 1 CreditTM for physicians and is offered free of charge. The course is also available for CE credit for nursing professionals. Go to online CME for course details and accreditation information, or go to CME: Myelomeningocele to register and take the course.
The Spring 2011 issue of In Utero Insights, the Center's newsletter to the professional community, focused on the landmark MOMS trial that found prenatal repair of myelomeningocele can substantially improve outcomes. This newsletter is also available in Spanish (en Español).
Prenatal repair of myelomeningocele. ©CHOP A 27-year-old woman was referred for assessment of a 23-week gestation fetus with thoracolumbosacral spina bifida. The lesion was first detected on a 20-week ultrasound performed because of an elevated maternal serum alpha-fetoprotein level.
The Center has detailed diagnosis-specific information about spina bifida and prenatal repair of spina bifida, as well as other fetal anomalies, written for families. Easy-to-understand diagnosis pages are available in English and Spanish (Español). Feel free to print out and share Children's Hospital resources with your patients. To access the Spanish content, look for the "en Español" tab under the banner of each page.
As new families investigate fetal surgery for spina bifida, some past patients talk about how their children are progressing after receiving this groundbreaking surgery.
In our DVD, Birth of a Breakthrough, Center team members explain the prenatal myelomeningocele repair procedure and the comprehensive, multidisciplinary care provided for both mother and baby at The Children's Hospital of Philadelphia. Created for clinicians and patients, it's essential information about this important treatment advance.
Staff of the Center for Fetal Diagnosis and Treatment have written extensively about fetal surgery for spina bifida and have established a long legacy of research about myelomeningocele. See below for a selection of recent peer-reviewed publications.
Bebbington MW, Danzer E, Johnson MP, Adzick NS. Open fetal surgery for myelomeningocele. Prenat Diagn. 2011 Jul;31(7):689-94. doi: 10.1002/pd.2805. Epub 2011 Jun 8. Review.
For more information, to refer a patient or discuss a case with a member of our team, please contact us at 1-800-IN-UTERO (1-800-468-8376) or use our online form.
We are available 24 hours a day/7 days a week.